AQA
LGND icon

Alpha Quant Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Alpha Quant Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$19K Sell
240
-57
-19% -$4.32K 0.02% 173
2018
Q4 		$25K Buy
+297
New +$31.7K 0.03% 140

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Alpha Quant Advisors's LGND Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Ligand Pharmaceuticals (LGND) stake by 19% in Q1 2019, selling an estimated $4.32K and leaving 240 shares worth $19K. The position accounts for 0.02% of the portfolio, ranked #173.

Alpha Quant Advisors first reported a position in LGND in Q4 2018 and has held it in 2 quarters since. The position peaked at $25K in Q4 2018. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Alpha Quant Advisors held 240 shares of Ligand Pharmaceuticals worth $19K as of Q1 2019.
  • Alpha Quant Advisors sold 57 Ligand Pharmaceuticals shares in Q1 2019, an estimated $4.32K.
  • Ligand Pharmaceuticals made up 0.02% of Alpha Quant Advisors's portfolio in Q1 2019, its #173 holding.
  • Alpha Quant Advisors first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Ligand Pharmaceuticals position peaked at $25K in Q4 2018.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.